
T2 Biosystems TTOO
Quarterly report 2024-Q3
added 11-14-2024
T2 Biosystems PEG Ratio 2011-2026 | TTOO
Annual PEG Ratio T2 Biosystems
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -0.000062 | -0 | -0.000029 | -0.0898 | 0.238 | -0.0767 | -0.317 | -0.576 | -0.0859 | 0.0349 | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 0.238 | -0.576 | -0.0872 |
PEG Ratio of other stocks in the Diagnostics research industry
| Issuer | PEG Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Centogene N.V.
CNTG
|
-3.07 | - | -6.23 % | $ 30.6 M | ||
|
Aspira Women's Health
AWH
|
-0.0104 | - | -6.19 % | $ 10.5 M | ||
|
Agilent Technologies
A
|
2.05 | $ 115.39 | -1.31 % | $ 35.1 B | ||
|
Biocept
BIOC
|
-0.000363 | - | -13.05 % | $ 7.29 M | ||
|
BioNano Genomics
BNGO
|
-0.000157 | $ 1.16 | -1.69 % | $ 6.32 M | ||
|
Chembio Diagnostics
CEMI
|
-0.0363 | - | 0.22 % | $ 16.8 M | ||
|
DermTech
DMTK
|
-0.847 | - | -11.32 % | $ 2.94 M | ||
|
CareDx, Inc
CDNA
|
-1.49 | $ 16.69 | -6.86 % | $ 889 M | ||
|
Oxford Immunotec Global PLC
OXFD
|
2.29 | - | - | $ 562 M | ||
|
Akumin
AKU
|
0.0277 | - | -17.87 % | $ 25.9 M | ||
|
Enzo Biochem
ENZ
|
-0 | - | -8.98 % | $ 14.8 K | ||
|
Burning Rock Biotech Limited
BNR
|
0.283 | $ 16.25 | 0.06 % | $ 175 M | ||
|
Exact Sciences Corporation
EXAS
|
-0.798 | - | - | $ 19.8 B | ||
|
Co-Diagnostics
CODX
|
-0.000246 | $ 4.4 | 101.83 % | $ 5.85 M | ||
|
Accelerate Diagnostics
AXDX
|
0.114 | - | -61.36 % | $ 2.46 M | ||
|
Castle Biosciences
CSTL
|
0.278 | $ 23.43 | -6.99 % | $ 651 M | ||
|
Global Cord Blood Corporation
CO
|
0.0591 | - | - | $ 399 M | ||
|
Fluidigm Corporation
FLDM
|
-0.383 | - | 1.08 % | $ 308 M | ||
|
Genetic Technologies Limited
GENE
|
62.6 | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
-0.00417 | - | 0.12 % | $ 80.1 M | ||
|
Charles River Laboratories International
CRL
|
9.49 | $ 175.55 | 0.27 % | $ 8.7 B | ||
|
PRA Health Sciences, Inc.
PRAH
|
-2.1 | - | - | $ 10.7 B | ||
|
Danaher Corporation
DHR
|
210 | $ 192.99 | -1.63 % | $ 138 B | ||
|
Heska Corporation
HSKA
|
3.41 | - | - | $ 1.31 B | ||
|
HTG Molecular Diagnostics
HTGM
|
-0.00137 | - | -20.0 % | $ 1.06 M | ||
|
Interpace Biosciences
IDXG
|
-0.00238 | $ 2.3 | 16.02 % | $ 10.2 M | ||
|
Illumina
ILMN
|
2.16 | $ 123.67 | -3.38 % | $ 19.7 B | ||
|
Fulgent Genetics
FLGT
|
-0.00389 | $ 15.02 | -5.12 % | $ 454 M | ||
|
Koninklijke Philips N.V.
PHG
|
-0.461 | $ 28.13 | 0.29 % | $ 20 B | ||
|
Guardant Health
GH
|
-3.43 | $ 87.17 | -6.11 % | $ 10.9 B | ||
|
QIAGEN N.V.
QGEN
|
3.43 | - | - | $ 10.6 B | ||
|
Anixa Biosciences
ANIX
|
-0 | $ 2.74 | 0.37 % | $ 88.9 K | ||
|
Biomerica
BMRA
|
-0.0105 | $ 2.2 | 2.33 % | $ 5.05 M | ||
|
ICON Public Limited Company
ICLR
|
1.16 | $ 106.7 | 0.15 % | $ 8.8 B | ||
|
Check-Cap Ltd.
CHEK
|
-0.0368 | - | - | $ 9.42 M | ||
|
Laboratory Corporation of America Holdings
LH
|
22.7 | $ 273.26 | -0.53 % | $ 22.7 B | ||
|
Celcuity
CELC
|
-0.769 | $ 124.64 | 6.58 % | $ 5.83 B | ||
|
Medpace Holdings
MEDP
|
0.906 | $ 501.5 | -3.68 % | $ 14.5 B | ||
|
Lantheus Holdings
LNTH
|
-0.338 | $ 81.43 | 1.75 % | $ 5.5 B | ||
|
Motus GI Holdings
MOTS
|
-0.069 | - | -34.28 % | $ 263 K | ||
|
Myriad Genetics
MYGN
|
-0.00983 | $ 4.44 | -6.92 % | $ 411 M | ||
|
Quest Diagnostics Incorporated
DGX
|
6.06 | $ 197.82 | -0.5 % | $ 22 B | ||
|
NeoGenomics
NEO
|
0.0904 | $ 7.94 | -3.38 % | $ 1.02 B | ||
|
Neogen Corporation
NEOG
|
0.00738 | $ 10.04 | -2.95 % | $ 2.18 B | ||
|
ENDRA Life Sciences
NDRA
|
-0.000061 | $ 5.31 | 2.71 % | $ 4.18 M | ||
|
National Research Corporation
NRC
|
-7.14 | $ 17.05 | -1.22 % | $ 382 M | ||
|
Natera
NTRA
|
-0.401 | $ 203.0 | -3.71 % | $ 20 B | ||
|
Invitae Corporation
NVTA
|
0.225 | - | - | $ 21.2 M | ||
|
Organovo Holdings
ONVO
|
0.0583 | - | -2.3 % | $ 19.4 M | ||
|
OpGen
OPGN
|
0.00227 | - | -16.95 % | $ 1.54 M |